Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, forecasts that the insomnia drug market will exceed $5.6 billion in 2013. The new Pharmacor study entitled Insomnia finds that upcoming launches of three new drugs from Sepracor, Pfizer, and Sanofi-Aventis will drive the market.

"Growth in the U.S. market, which represents more than 75% of the seven- country insomnia market, will drive overall growth of the worldwide market because of the relatively high price of drugs in this country and the comparatively aggressive marketing of prescription drugs directly to patients in the United States," said Tricia Nagle, analyst at Decision Resources. "Insomniacs are an ideal target for direct-to-consumer advertising because so many individuals suffer from the condition but fail to discuss it with their primary care providers."

Ms. Nagle continued: "Overall growth of elderly populations in the seven major pharmaceutical markets we cover (United States, France, Germany, Italy, Spain, United Kingdom, and Japan) will also expand the potential market for insomnia therapies in the next ten years because insomnia is especially prevalent among elderly individuals. This segment of the insomnia population remains highly untapped."

About Insomnia

Insomnia--defined as difficulty initiating and/or maintaining sleep with accompanying daytime disability--affects more than 130 million people in the seven major pharmaceutical markets. Only a small percentage of insomniacs currently seek professional help for their condition.

About Pharmacor from Decision Resources

Pharmacor is a unique family of studies that assesses a host of market- impacting factors and analyzes the commercial outlook for drugs in research and development.

About Decision Resources

Decision Resources, Inc., ( is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Elizabeth Marshall    Decision Resources, Inc.    781-296-2563 

SOURCE: Decision Resources, Inc.

CONTACT: Elizabeth Marshall of Decision Resources, Inc., +1-781-296-2563,

Managed Care Organizations Stall The Insomnia Drug Market

View Now